^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

PD-L1 underexpression

i
Other names: PD-L1, CD274, HPD-L1, PD-L1, B7H1, PDL1, Programmed death ligand 1, B7-H1, B7-H, PDCD1L1, PDCD1LG1, PDCD1 Ligand 1, B7 homolog 1, CD274 Antigen, Programmed cell death 1 ligand 1, CD274 molecule
Entrez ID:
Related biomarkers:
1year
Clinical • Review
|
PD-L1 (Programmed death ligand 1) • STK11 (Serine/threonine kinase 11) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A)
|
PD-L1 underexpression • PD-1-L • PD-L1-L
2years
Clinical • IO biomarker
|
PD-L1 (Programmed death ligand 1) • ALK (Anaplastic lymphoma kinase)
|
PD-L1 expression • PD-L1 overexpression • PD-L1 underexpression • PD-1-L
almost3years
Clinical
|
PD-L1 (Programmed death ligand 1)
|
PD-L1 expression • PD-L1 underexpression • PD-L1 negative • PD-1-L
|
VENTANA PD-L1 (SP263) Assay
almost3years
Retrospective data
|
EGFR (Epidermal growth factor receptor) • PD-L1 (Programmed death ligand 1)
|
PD-L1 underexpression • PD-1-L
almost3years
PD-L1 (Programmed death ligand 1)
|
PD-L1 underexpression • PD-L1 negative
|
Keytruda (pembrolizumab)
almost4years
PD(L)-1 Biomarker
|
EGFR (Epidermal growth factor receptor) • PD-L1 (Programmed death ligand 1) • KRAS (KRAS proto-oncogene GTPase) • TP53 (Tumor protein P53) • STK11 (Serine/threonine kinase 11)
|
PD-L1 expression • PD-L1 underexpression